<DOC>
	<DOC>NCT02854644</DOC>
	<brief_summary>This study evaluates the frequency of the spontaneous T cells specific CD4 answers of tumoral antigens breast cancer and glioma.</brief_summary>
	<brief_title>Study of the Anti-tumoral Immune Response</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Glioma</mesh_term>
	<criteria>Performance status 0,1 or 2 breast cancer or glioma Arm glioma: patients without antitumoral treatment Arm breast cancer: inclusion before treatment Arm breast cancer HER2: patients with current therapy Psychiatric disease compromising the understanding of the information or the realization of the study vulnerable People according to the law (minors, adults under protection, private persons of freedom ...) Unaffiliated People to the Social Security People being for the period of exclusion from another study Life expectancy estimated unless 3 months. For patients in Arm glioma: patients having already begun a systematic treatment. For patients with a breast cancer: patient already under current therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>